Virtual Reality for Pain and Anxiety in Pediatric Dental Treatment
30 juni 2026 bijgewerkt door: Randa Soussou, University of British Columbia
Effects of Immersive Virtual Reality on Pain, Anxiety, and Post-Procedural Experience in Pediatric Dental Treatment: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether immersive virtual reality (VR) reduces pain and anxiety in children aged 6-12 years during routine dental procedures. The main questions it aims to answer are:
- Does VR distraction reduce self-reported pain and anxiety during dental treatment compared to standard behaviour guidance?
- Does VR distraction improve children's post-procedural experience and willingness to return for future dental visits?
Researchers will compare children using a VR headset during dental treatment to children receiving standard behaviour guidance techniques.
Participants will:
- Attend one routine dental appointment
- Be randomly assigned to wear a VR headset or receive standard care during their procedure
- Complete brief questionnaires about pain and anxiety before and after treatment
- Receive a follow-up phone call 24-72 hours after the appointment
Studie Overzicht
Toestand
Nog niet aan het werven
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Geschat)
80
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Randa Soussou
- Telefoonnummer: 604-822-6819
- E-mail: randa.soussou@dentistry.ubc.ca
Studie Locaties
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z3
- UBC Graduate Pediatric Dental Clinic
-
Contact:
- Randa Soussou
- Telefoonnummer: 604-822- 6819
- E-mail: randa.soussou@dentistry.ubc.ca
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- Children aged 6 to 12 years
- Scheduled for a routine invasive dental procedure
- Accompanied by a parent or legal guardian
- Parent/guardian able to provide written informed consent
Exclusion Criteria:
- Children with visual or hearing impairments that would prevent use of the VR headset
- Children with a history of motion sickness
- Children with severe cognitive or developmental delays that would prevent completion of study measures
- Children who have previously participated in this study
- Children requiring emergency dental treatment
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: VR Distraction
Children wear an immersive VR headset during routine dental treatment as a non-pharmacological distraction intervention.
The VR headset provides an engaging visual and auditory environment to reduce pain and anxiety during the procedure.
|
A commercially available immersive VR headset used as a non-pharmacological distraction tool during routine pediatric dental procedures.
Children wear the headset throughout their treatment to engage with an interactive virtual environment designed to reduce pain and anxiety.
|
|
Actieve vergelijker: Standard Behaviour Guidance
Children receive standard behaviour guidance techniques commonly used in pediatric dentistry, such as tell-show-do and positive reinforcement, without VR distraction.
|
Standard behaviour guidance techniques routinely used in pediatric dentistry, including tell-show-do, positive reinforcement, and distraction through verbal communication and a TV screen.
No virtual reality headset is used.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Self-Reported Pain During Dental Procedure Using Faces Pain Scale
Tijdsspanne: Baseline Pre-procedural and Immediately following the dental procedure (same day)
|
Child self-reported pain assessed using the Faces Pain Scale (0-10 where 10 is the maximum pain felt): The child is asked to point to the Faces picture that reflect the pain level that they are feeling.
0= Relaxed and comfortable; 2-4= Mild discomfort; 6-8= Moderate pain; 10= Severe pain or discomfort Baseline pre-procedural and immediately following the dental procedure.
|
Baseline Pre-procedural and Immediately following the dental procedure (same day)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Physiological Stress Response (Heart Rate)
Tijdsspanne: Baseline (Before the procedure), during and Immediately following the dental procedure
|
Physiological markers of stress assessed via heart rate using a pulse oximeter device (pulse/minute)
|
Baseline (Before the procedure), during and Immediately following the dental procedure
|
|
Physiological Stress Response (Salivary alpha-Amylase) salivary alpha-amylase level (U/L) baseline before any dental treatment and immediately following the dental procedure
Tijdsspanne: Salivary alpha-amylase level (U/L), measured at baseline (immediately prior to the start of the dental procedure) and again immediately following the dental procedure. Both samples are collected on the same day, during the single dental appointment.
|
Using a swab to collect for a full 60-90 seconds by resting the swab inside the mouth, or collect in intervals by re-introducing the swab into the mouth as needed, until the lower third of the swab is saturated (some participants may require longer than 90 seconds of total collection time).
Salivary alpha-amylase level (U/L), measured at baseline (immediately prior to the start of the dental procedure) and again immediately following the dental procedure.
Both samples are collected on the same day, during the single dental appointment.
|
Salivary alpha-amylase level (U/L), measured at baseline (immediately prior to the start of the dental procedure) and again immediately following the dental procedure. Both samples are collected on the same day, during the single dental appointment.
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
2 juni 2026
Primaire voltooiing (Geschat)
18 juni 2027
Studie voltooiing (Geschat)
30 juni 2027
Studieregistratiedata
Eerst ingediend
22 mei 2026
Eerst ingediend dat voldeed aan de QC-criteria
4 juni 2026
Eerst geplaatst (Werkelijk)
9 juni 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
2 juli 2026
Laatste update ingediend die voldeed aan QC-criteria
30 juni 2026
Laatst geverifieerd
1 juni 2026
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- H25-03739 (Andere identificatie: UBC Clinical Research Ethics Board)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
ONBESLIST
Beschrijving IPD-plan
A decision regarding individual participant data sharing has not yet been made.
This study involves children (a vulnerable population) and data sharing plans will be determined in accordance with UBC Research Ethics Board requirements
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .